Substance
ID:348086
Names and Identifiers
IUPAC Traditional name
levetiracetam
IUPAC name
(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
Synonyms
(αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide2(S)-(2-oxopyrrolidin-1-yl)butyramideLevetiracetamKeppra®
Properties
Product Information
Purity
≥98% (HPLC)
Empirical Formula (Hill Notation)
C8H14N2O2
Safety Information
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
RTECS
UX9656166
Safety Statements
26
Risk Statements
22-36
European Hazard Symbols
Harmful (Xn)GHS Signal Word
Warning
MSDS Link
GHS Pictograms
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
GHS Hazard statements
H302-H319
German water hazard class
3
GHS Precautionary statements
P305+P351+P338
Physical Property
Solubility
H2O: >5 mg/mL
Apperance
white powder
Molecule Details
Biochem/physiol Actions
Levetiracetam is a pyrrolidine with antiepileptic activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity.
Levetiracetam is a pyrrolidine with antiepileptic activity. Stereoselective binding of levetiracetam was confined to synaptic plasma membranes in the central nervous system with no binding occurring in peripheral tissue. Levetiracetam inhibits burst firing without affecting normal neuronal excitability, which suggests that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data